Investor Relations


Henrik cropped

Henrik Lundkvist


Send mail

For investors

Probi is a Swedish, science-driven B2B company. We create value for investors by providing customers around the world with highly effective and well-documented probiotic strains, coupled with vital expertise and support. Stay informed as we strive towards being the first name in premium probiotics in the world’s most important health markets.

The Share

Key information about Probi's share and its ownership.

Press releases

Your access to latest press releases.

Financial reports

Download the latest annual and interim financial reports, as well as the sustainability reports and prospectuses.

Business strategy

Read about Probi's strategic focus areas.

Finanical goals

Learn more about Probi's financial goals.

Key figures

Get the latest year-end figures regarding income, financial position, cash flow and more.

Investment case

Why you should invest in Probi.

Management & Board of Directors

See who's in charge of the day-to-day and who's on the board.

Corporate Governance

Find our articles of association and information about how Probi is governed.


Watch Probi's quarterly audiocasts.

Financial calendar

Important dates for upcoming financial reports and the Annual General Meeting.

EMEA (Probi HQ)

Probi AB
Ideongatan 1A
223 70 Lund
Tel: +46 46 2868920


Probi Asia-Pacific Pte Ltd
226 Pandan Loop
Singapore 128412

Tel: +65 6635 1939


Probi USA Inc.
9609 153rd Avenue NE
Redmond WA 98052
Tel: + 1 425 883 9518